Cas no 924307-76-6 ((2S)-2-aminonon-8-enoic acid)

(2S)-2-aminonon-8-enoic acid is a non-proteinogenic α-amino acid featuring a terminal alkene group at the C8 position. Its chiral (S)-configuration and unsaturated side chain make it a valuable building block in organic synthesis and peptide modification. The compound’s structural versatility allows for selective functionalization, including cross-coupling or click chemistry via the alkene moiety, while the free amine and carboxyl groups enable standard peptide coupling strategies. This amino acid is particularly useful in medicinal chemistry for designing constrained peptides or bioactive analogs. Its well-defined stereochemistry ensures reproducibility in research applications, and its stability under typical handling conditions facilitates practical use in synthetic workflows.
(2S)-2-aminonon-8-enoic acid structure
(2S)-2-aminonon-8-enoic acid structure
Product Name:(2S)-2-aminonon-8-enoic acid
CAS No:924307-76-6
MF:C9H17NO2
MW:171.23678278923
MDL:MFCD11977264
CID:796828
PubChem ID:16655537
Update Time:2025-11-06

(2S)-2-aminonon-8-enoic acid Chemical and Physical Properties

Names and Identifiers

    • (S)-2-Aminonon-8-enoic acid
    • (2S)-2-Amino-8-nonenoic acid
    • (2S)-2-aminonon-8-enoic acid
    • 8-Nonenoic acid, 2-amino-,(2S)-
    • DS-4137
    • AMY6921
    • LKMSSWRWDBZUFC-QMMMGPOBSA-N
    • (S)-2-Aminonon-8-enoicacid
    • CS-0006844
    • 924307-76-6
    • 8-Nonenoic acid, 2-amino-, (2S)-
    • SCHEMBL864553
    • EN300-1297916
    • MFCD11977264
    • DTXSID20586518
    • AKOS015892805
    • C77165
    • (S)-2-Aminonon-8-enoic acid (H-L-Nle(All)-OH)
    • MDL: MFCD11977264
    • Inchi: 1S/C9H17NO2/c1-2-3-4-5-6-7-8(10)9(11)12/h2,8H,1,3-7,10H2,(H,11,12)/t8-/m0/s1
    • InChI Key: LKMSSWRWDBZUFC-QMMMGPOBSA-N
    • SMILES: OC([C@H](CCCCCC=C)N)=O

Computed Properties

  • Exact Mass: 171.125928785g/mol
  • Monoisotopic Mass: 171.125928785g/mol
  • Isotope Atom Count: 0
  • Hydrogen Bond Donor Count: 2
  • Hydrogen Bond Acceptor Count: 3
  • Heavy Atom Count: 12
  • Rotatable Bond Count: 7
  • Complexity: 146
  • Covalently-Bonded Unit Count: 1
  • Defined Atom Stereocenter Count: 1
  • Undefined Atom Stereocenter Count : 0
  • Defined Bond Stereocenter Count: 0
  • Undefined Bond Stereocenter Count: 0
  • XLogP3: -0.4
  • Topological Polar Surface Area: 63.3?2

Experimental Properties

  • Density: 1.002
  • Melting Point: 200-201℃ (DEC.)
  • Boiling Point: 303℃ at 760 mmHg
  • Flash Point: 137℃

(2S)-2-aminonon-8-enoic acid Pricemore >>

Related Categories No. Product Name Cas No. Purity Specification Price update time Inquiry
CHENG DOU FEI BO YI YAO Technology Co., Ltd.
FD03035-5g
(S)-2-aminonon-8-enoic acid
924307-76-6 95%
5g
$3600 2023-09-07
Fluorochem
229903-1g
S)-2-Aminonon-8-enoic acid
924307-76-6 95%
1g
£256.00 2022-02-28
Fluorochem
229903-5g
S)-2-Aminonon-8-enoic acid
924307-76-6 95%
5g
£896.00 2022-02-28
Fluorochem
229903-10g
S)-2-Aminonon-8-enoic acid
924307-76-6 95%
10g
£1522.00 2022-02-28
SHANG HAI JI ZHI SHENG HUA Technology Co., Ltd.
S34120-1g
(S)-2-Aminonon-8-enoic acid
924307-76-6
1g
¥1816.0 2021-09-07
SHANG HAI JI ZHI SHENG HUA Technology Co., Ltd.
S34120-100mg
(S)-2-Aminonon-8-enoic acid
924307-76-6
100mg
¥586.0 2021-09-07
SHANG HAI JI ZHI SHENG HUA Technology Co., Ltd.
S34120-250mg
(S)-2-Aminonon-8-enoic acid
924307-76-6
250mg
¥756.0 2021-09-07
Chemenu
CM255796-1g
(S)-2-Aminonon-8-enoic acid
924307-76-6 95%
1g
$729 2021-06-09
Chemenu
CM255796-5g
(S)-2-Aminonon-8-enoic acid
924307-76-6 95%
5g
$2038 2021-06-09
SHANG HAI XIAN DING Biotechnology Co., Ltd.
B-GE836-1g
(2S)-2-aminonon-8-enoic acid
924307-76-6 95+%
1g
6773CNY 2021-05-08

Additional information on (2S)-2-aminonon-8-enoic acid

Market Research and Analysis of (2S)-2-Aminonon-8-enoic Acid (924307-76-6) in Chemical-Biomedical Fields

The compound (2S)-2-aminonon-8-enoic acid, identified by the CAS registry number 924307-76-6, has garnered significant attention in recent years due to its potential applications in the chemical-biomedical industry. This compound is a non-proteinogenic amino acid with a unique structure that includes an eight-carbon chain and an unsaturated bond, making it a promising candidate for various research and development activities.

Recent studies have highlighted the role of (2S)-2-aminonon-8-enoic acid in biochemistry and pharmacology. Its stereochemistry, particularly the S configuration at the second carbon, is crucial for its biological activity. This compound has been explored for its potential as a building block in drug design, as well as for its role in metabolic pathways and enzyme inhibition studies.

The global market demand for (2S)-2-aminonon-8-enoic acid is driven by its applications in academic research, preclinical studies, and early-stage drug development. Key players in the chemical and pharmaceutical industries are increasingly investing in the synthesis and characterization of this compound to meet the growing demand from research institutions and biotech companies.

From a supply chain perspective, several global suppliers specializing in fine chemicals and biochemicals now offer (2S)-2-aminonon-8-enoic acid at various scales. These suppliers cater to both small-scale research requirements and larger-scale production needs, ensuring a steady supply to meet the increasing demand across different regions.

In terms of market trends, there is a growing interest in the use of this compound for therapeutic applications. Preclinical studies have demonstrated its potential as an inhibitor of specific enzymes involved in metabolic disorders, suggesting its role in the development of novel treatments for conditions such as diabetes and neurodegenerative diseases.

To address these opportunities, researchers are focusing on optimizing synthetic routes to improve the yield and purity of (2S)-2-aminonon-8-enoic acid. Additionally, efforts are being made to explore its pharmacokinetic properties and toxicity profiles to support its transition from preclinical studies to clinical trials.

In conclusion, (2S)-2-aminonon-8-enoic acid (924307-76-6) represents a valuable asset in the chemical-biomedical landscape. Its unique properties and potential applications make it a focal point for ongoing research and development activities. As the market continues to evolve, collaborations between academia, industry, and regulatory bodies will be essential to unlock its full potential and bring innovative solutions to patients worldwide.

Recommended suppliers
Suzhou Genelee Bio-Technology Co., Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Suzhou Genelee Bio-Technology Co., Ltd.
Zhejiang Brunova Technology Co., Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Zhejiang Brunova Technology Co., Ltd.
Hangzhou Cedareal Technology Co., Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Hangzhou Cedareal Technology Co., Ltd.
Shanghai Jinhuan Chemical CO., LTD.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Shanghai Jinhuan Chemical CO., LTD.
Yunnanjiuzhen
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Yunnanjiuzhen